Applus+ Laboratories opens its largest global mechanical-testing facility in China

The new facility represents a major expansion of the company’s capabilities in China and Asia and reinforces its position as a strategic testing and certification partner for medical devices, advanced materials and high-technology industries.

Located in one of China’s most important industrial and innovation regions, the Changzhou laboratory combines advanced equipment, extensive testing capacity and a highly specialized technical team. It will support customers throughout the product-development cycle, from material characterization and engineering validation to regulatory testing, quality assurance, and market access.

Advanced materials and components testing

The Changzhou facility significantly expands Applus+ Laboratories’ capabilities in the testing of composite materials, raw materials, components, and complete structures.

Its services support the development of lightweight, durable and high-performance products for demanding applications across renewable energy, automotive and new mobility, aerospace, construction, marine, defense and other advanced industrial and connected technologies.

The laboratory provides comprehensive services covering:

• Characterization and performance testing of raw and composite materials 
• Mechanical, structural, fatigue and durability testing 
• Testing of components and larger structures 
• Engineering analysis and product-performance validation 
• Support for research and development, industrialization and production quality control

These capabilities will help manufacturers accelerate innovation, validate new technologies and improve the safety, reliability and performance of their products.

Strengthening medical-device testing capabilities

The new laboratory also strengthens Applus+ Laboratories’ medical-device testing platform in China and Asia.

Building on the expertise of Applus+ De.testing, the Changzhou team provides specialized mechanical testing and simulation services for medical devices, including orthopedic, cardiovascular and other implantable and non-implantable products.

The facility supports manufacturers across the complete product lifecycle, including:

• Design evaluation and engineering simulation 
• Mechanical performance and structural validation 
• Fatigue, durability and functional testing 
• Product verification and type testing 
• Technical evidence supporting regulatory submissions and international market access 
• Post-market product evaluation

By combining local laboratory capabilities with the international testing and certification network of Applus+ Laboratories, the Changzhou facility will help medical-device manufacturers access coordinated services for China, Europe, the United States and other global markets.

A strategic platform for China and Asia

The opening of the Changzhou laboratory marks another important step in the continued expansion of Applus+ Laboratories across Asia. It increases the company’s capacity to support both Chinese and international customers with advanced local testing capabilities, global technical expertise and access to international markets.

The investment also reflects the company’s long-term commitment to China and to the development of high-value industries that are shaping the future of energy, mobility, healthcare and advanced manufacturing.

Through the new Changzhou facility, Applus+ Laboratories will continue helping customers accelerate innovation, demonstrate product performance and safety, and successfully bring advanced technologies to markets worldwide.